Not sheltering terror, says China accused of ‘shameful hypocrisy’ by US on Azhar ban

Agencies
March 30, 2019

Beijing, Mar 30 : Defending its repeated attempts to block the listing of JeM chief Masood Azhar as a global terrorist by the UN, China on Friday refuted US allegation that its action amounted to protecting violent Islamic groups from sanctions.

US Secretary of State Mike Pompeo on Wednesday denounced China of its “shameful hypocrisy” toward Muslims, saying China abuses more than a million Muslims at home, but on the other it protects violent Islamic terrorist groups from sanctions at the UN.”

Pompeo had said it in apparent reference to China’s move to block India’s proposal at the United Nations to designate Jaish-e-Mohammad chief Azhar as a global terrorist.

Reacting to this, Chinese Foreign Ministry spokesman Geng Shuang told a media briefing here on Friday that if that is so, the country that had put most technical holds in the 1267 Al Qaeda Sanctions Committee of the Security Council should have been sheltering more terrorists.

At the UN Sanctions committee, the practice of putting technical hold is in line with the rules of the Committee, he asserted.

Without directly referring to the US, Geng said, “If a certain country accuses China of sheltering terrorists by putting technical hold, does that mean all the countries that put such holds are sheltering terrorists? If this makes sense then shall we say the country that put most hold is the biggest shelter of terrorists?”

China has so far blocked the move four times in recent years. It recently blocked a US, UK and France resolution in the counter terrorism 1267 committee with “technical hold” saying that it provides time and space for the relevant parties to hold talks after the Pulwama terrorist attack.

Following this, the US has directly moved a resolution in the UN Security Council on Thursday to blacklist Azhar which China said amounted to undermining the 1267 committee.

Defending China’s move to block Azhar’s listing, Geng said, “China put forward a technical hold with a purpose of conducting in-depth assessment so as to give enough time and space for the dialogue and consultation between parties. China is in communication with all parties to seek a settlement through dialogue. We hope this will be a common goal of all the members of the UNSC.” Asked about Pakistan rejecting the evidence put forward by India on the Pulwama terrorist attack, he said, “the 1267 committee has detailed and clear stipulation and requirements on the listing issue.”

What China has done is in line with the requirement of the UNSC and rules and procedures of the committee. We are always working in a constructive manner and stay in communication with the relevant parties and seek a proper solution.

“It is improper to reveal to you the detailed discussions,” he said.

To another question whether China is preparing to defend its stand in the UNSC when the latest US resolution would come up for discussion, Geng said, “China stayed in close communication with all parties on the listing issue.

We will act in a responsible and a constructive manner to participate in the discussion at the committee. We also hope to work with various parties to seek a proper settlement to the issue”, he said.

China on Thursday asked the US not to complicate the listing of Azhar as a global terrorist by “forcefully moving” a resolution directly in the UNSC, undermining the authority of the UN’s anti-terrorism committee.

“This is not in line with resolution of the issue through dialogue and negotiations. This has reduced the authority of the Committee as a main anti-terrorism body of the UNSC and this is not conducive to the solidarity and only complicates the issue.

“We urge the US to act cautiously and avoid forcefully moving forward this draft resolution,” Geng said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 3,2020

New Delhi, Jan 3: US aviation regulator Federal Aviation Administration on Thursday warned America's airlines and their pilots that there is risk involved in operating flights in Pakistan airspace due to "extremist or militant activity", according to an official document.

"Exercise caution during flight operations. There is a risk to US civil aviation operating in the territory and airspace of Pakistan due to extremist/militant activity," said the US Federal Aviation Administration (FAA) in a notice to airmen (NOTAM) dated December 30, 2019.

The NOTAM is applicable to all US-based airlines and US-based pilots.

The US regulator said in its NOTAM that there continues to be a risk to US civil aviation sector from attacks against airports and aircraft in Pakistan, particularly for aircraft on the ground and aircraft operating at low altitudes, including during the arrival and departure phases of flights.

"The ongoing presence of extremist/militant elements operating in Pakistan poses a continued risk to US civil aviation from small-arms fire, complex attacks against airports, indirect weapons fire, and anti-aircraft fire, any of which could occur with little or no warning," it said.

The FAA said that while, to date, there have been no reports of man-portable air defense systems or Manpads being used against the civil aviation sector in Pakistan, some extremist or terrorist groups operating there are suspected of having access to these Manpads.

"As a result, there is potential risk for extremists/militants to target civil aviation in Pakistan with Manpads," it said.

The regulator added that pilots or airlines must report safety or security incidents - which may happen in Pakistan - to the FAA.

Pakistan on July 16 last year opened its airspace for India after about five months of restrictions imposed in the wake of a standoff with New Delhi.

Following the Balakot airstrikes by the Indian Air Force, Pakistan had closed its airspace on February 26 last year.

Pakistan in October last year had denied India's request to allow Prime Minister Narendra Modi's VVIP flight to use its airspace for his visit to Saudi Arabia over the Jammu and Kashmir issue.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 6,2020

Islamabad, Jun 6: Pakistan has reported a record 97 COVID-19 deaths in a single day, taking the total number of fatalities to 1,935, while the number of confirmed cases in the country approached 94,000 after over 4,700 infections were detected, the health ministry said on Saturday.

Punjab registered 35,308 COVID-19 cases, Sindh 34,889, Khyber-Pakhtunkhwa 12,459, Balochistan 5,776 Islamabad 4,323, Gilgit-Baltistan 897 and Pakistan-occupied Kashmir 331 cases, the Ministry of National Health Services said.

The total number of COVID-19 cases reached 93,983 after 4,734 new infections were detected across the country, it said.

With a record 97 fatalities in one day, the death toll in the country has reached 1,935, while 32,581 people have recovered from the disease.

The ministry said that the total number of active COVID-19 cases in Pakistan are 59,467, out of which 1,265 patients are in critical condition.

More than 100 labs in the country have so far conducted 660,508 tests, including 22,185 in the last 24 hours.

There are 747 hospitals across the country with COVID-19 treatment facilities where 5,060 patients are being treated. Others have been asked to self-isolate at home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.